Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Evogene completes US IPO

The Israeli biotechnology company, Evogene (Rehovot), has raised $84.8 million in its US initial public offering. The company sold 5.75 million ordinary shares at $14.75/share on the New York Stock Exchange in its US IPO this month (Agrow No 677, p 6). That includes the exercise in full by the underwriters of their option to purchase up to 750,000 additional ordinary shares. Evogene intends to use about half of the proceeds from the IPO on its seed trait research, with the remainder being targeted at "ag chemicals" and biofuels (Agrow ibid).

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG000742

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel